Evidence map›Paper›PMID 12502846›Full record

ArticleJournal of virology2003

The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1.

D Perkins, E F R Pereira, L Aurelian

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 90 citations in OpenAlex.

  1. Cell death network regulation in HSV infection: immune evasion versus host defense.Apoptosis : an international journal on programmed cell death · 2026
    Review
  2. Review
  3. Manipulation of Host Cell Death Pathways by Herpes Simplex Virus.Current topics in microbiology and immunology · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Human DNA Virus Exploitation of the MAPK-ERK Cascade.International journal of molecular sciences · 2019
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Infectious agents and neurodegeneration.Molecular neurobiology · 2012
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

D PerkinsDepartments of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore 21201, USA.
E F R Pereira
L Aurelian
University of Maryland, Baltimore · US

Funding

Nicotinic receptors: Role in hippocampal synaptic functionR01NS025296 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI ALBUQUERQUE, EDSON X · 1987 to 2012
$3.9M
MOLECULAR STUDIES OF ERYTHEMA MULTIFORMER01AR042647 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI AURELIAN, LAURE · 1994 to 2004
$1.3M
NIAMS NIH HHS AR42647NIAMS NIH HHS R01 AR042647NINDS NIH HHS NS25296NINDS NIH HHS R01 NS025296
6 · The paper itself

Abstract

Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) can trigger or block apoptosis in a cell type-dependent manner. We have recently shown that the protein kinase activity of the large subunit of the HSV-2 ribonucleotide reductase (R1) protein (ICP10 PK) blocks apoptosis in cultured hippocampal neurons by activating the extracellular signal-regulated kinase (ERK) survival pathway (Perkins et al., J. Virol. 76:1435-1449, 2002). The present studies were designed to better elucidate the mechanism of ICP10 PK-induced neuroprotection and determine whether HSV-1 has similar activity. The data indicate that apoptosis inhibition by ICP10 PK involves a c-Raf-1-dependent mechanism and induction of the antiapoptotic protein Bag-1 by the activated ERK survival pathway. Also associated with neuroprotection by ICP10 PK are increased activation/stability of the transcription factor CREB and stabilization of the antiapoptotic protein Bcl-2. HSV-1 and the ICP10 PK-deleted HSV-2 mutant ICP10DeltaPK activate JNK, c-Jun, and ATF-2, induce the proapoptotic protein BAD, and trigger apoptosis in hippocampal neurons. c-Jun activation and apoptosis are inhibited in hippocampal cultures infected with HSV-1 in the presence of the JNK inhibitor SP600125, suggesting that JNK/c-Jun activation is required for HSV-1-induced apoptosis. Ectopically delivered ICP10 PK (but not its PK-negative mutant p139) inhibits apoptosis triggered by HSV-1 or ICP10DeltaPK. Collectively, the data indicate that ICP10 PK-induced activation of the ERK survival pathway results in Bag-1 upregulation and overrides the proapoptotic JNK/c-Jun signal induced by other viral proteins.

Indexed as

Activating Transcription Factor 2AnimalsApoptosisCarrier ProteinsCaspase 3CaspasesChlorocebus aethiopsCyclic AMP Response Element-Binding ProteinDNA-Binding ProteinsEnzyme ActivationHerpesvirus 1, HumanHerpesvirus 2, HumanHippocampusMitogen-Activated Protein KinasesNeuronsPoly(ADP-ribose) PolymerasesActivating Transcription Factor 2BCL2-associated athanogene 1 proteinCarrier ProteinsCASP3 protein, humanCaspase 3CaspasesCyclic AMP Response Element-Binding ProteinDNA-Binding ProteinsICP10 protein, herpes simplex virus type 2Mitogen-Activated Protein KinasesPoly(ADP-ribose) PolymerasesProtein Serine-Threonine KinasesRibonucleotide ReductasesTranscription Factors

Identifiers

PMID12502846
PMCPMC140789
OpenAlexW2119533811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.